Tirzepatide goes under the PET scanner in new alcohol use disorder trial protocol
A published protocol details a randomized, double-blind crossover PET/MRI trial that will test whether tirzepatide modulates striatal dopamine signaling and ...
A published protocol details a randomized, double-blind crossover PET/MRI trial that will test whether tirzepatide modulates striatal dopamine signaling and ...
A new perspective in Frontiers in Psychiatry argues that comorbid depression and substance use disorder demand individualized, multidisciplinary treatment because ...
A published protocol describes a cluster-randomized controlled trial that will test whether a nurse care manager, primary care provider, remote ...
A retrospective cohort study of 4,232 hospitalizations found that only 11 percent of adults with alcohol use disorder left the ...
A randomized crossover trial found that heavy drinkers show a blunted cortical inhibition response to a high dose of baclofen ...
A 2026 editorial synthesizes epidemiological, clinical and preclinical evidence highlighting candidate pharmacological targets for alcohol use disorder while emphasizing that ...
A qualitative study of 15 adults in recovery from alcohol use disorder found that social norms and comparisons shaped participants’ ...
A planned protocol describes three separate open-label pilots assessing feasibility, acceptability, safety, tolerability and alcohol-consumption measures for off-label medications in ...
A scoping review of 26 studies found persistent underrecognition, delayed treatment and inconsistent thiamine prescribing in adults with alcohol use ...
A qualitative study in rural Uganda finds that primary care providers view WHO mhGAP-IG recommendations for alcohol use disorder as ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine